Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Goal of the 2013 WIN Symposium

Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller
Goal of the 2013 WIN Symposium ( Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller )
23 Apr 2013

Approaches to treatment of brain metastasis

Dr Elisabetta Munzone - European Institute of Oncology, Milan, Italy
Approaches to treatment of brain metastasis ( Dr Elisabetta Munzone - European Institute of Oncology, Milan, Italy )
23 Apr 2013

Myc inhibition in pre-clinical mouse models

Dr Laura Soucek - Vall d'Hebron Institute of Oncology
Myc inhibition in pre-clinical mouse models ( Dr Laura Soucek - Vall d'Hebron Institute of Oncology )
22 Apr 2013

Immunotherapy in melanoma and other cancers

Dr Suzanne Topalian – Johns Hopkins, Baltimore, USA
Immunotherapy in melanoma and other cancers ( Dr Suzanne Topalian – Johns Hopkins, Baltimore, USA )
19 Apr 2013

Next generation PI3 kinase inhibition

Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US
Next generation PI3 kinase inhibition ( Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US )
19 Apr 2013

Targeting tumour suppressor genes

Dr Douglas Lowy - National Cancer Institute, Bethesda, USA
Targeting tumour suppressor genes ( Dr Douglas Lowy - National Cancer Institute, Bethesda, USA )
19 Apr 2013

Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

Dr Darrin Stuart - Novartis Institutes for Biomedical Research, Emeryville, CA, USA
Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma ( Dr Darrin Stuart - Novartis Institutes for Biomedical Research, Emeryville, CA, USA )
8 Apr 2013

Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibitors

Dr Ahmed Samatar - Merck Research Laboratories, Boston, USA
Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibitors ( Dr Ahmed Samatar - Merck Research Laboratories, Boston, USA )
8 Apr 2013

Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers

Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA
Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers ( Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA )
8 Apr 2013

AKT inhibitor AZD5363 in patients with advanced solid tumours

Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom
AKT inhibitor AZD5363 in patients with advanced solid tumours ( Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom )
8 Apr 2013

Whole genome sequencing reveals underlying genetics of multiple myeloma

Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA
Whole genome sequencing reveals underlying genetics of multiple myeloma ( Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA )
4 Apr 2013

TIVO 1 study shows tivozanib an option for renal cell carcinoma

Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA
TIVO 1 study shows tivozanib an option for renal cell carcinoma ( Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA )
25 Feb 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation